HC Wainwright Analysts Give Edap Tms (EDAP) a $7.00 Price Target
HC Wainwright set a $7.00 target price on Edap Tms (NASDAQ:EDAP) in a report issued on Friday, TipRanks reports. The brokerage currently has a buy rating on the medical equipment provider’s stock.
Several other equities research analysts have also issued reports on EDAP. TheStreet raised shares of Edap Tms from a d+ rating to a c- rating in a research report on Thursday, February 14th. ValuEngine raised shares of Edap Tms from a hold rating to a buy rating in a research report on Wednesday, April 3rd. Finally, Zacks Investment Research raised shares of Edap Tms from a hold rating to a strong-buy rating and set a $5.50 price objective for the company in a research report on Tuesday, April 9th.
Shares of EDAP stock opened at $3.41 on Friday. Edap Tms has a one year low of $1.35 and a one year high of $5.42. The company has a quick ratio of 1.97, a current ratio of 2.40 and a debt-to-equity ratio of 0.09. The company has a market cap of $98.88 million, a P/E ratio of 170.50 and a beta of 1.90.
Several institutional investors have recently added to or reduced their stakes in the company. Hilton Capital Management LLC acquired a new stake in shares of Edap Tms in the first quarter worth $75,000. Commonwealth Equity Services LLC increased its position in shares of Edap Tms by 27.0% in the first quarter. Commonwealth Equity Services LLC now owns 23,500 shares of the medical equipment provider’s stock worth $70,000 after acquiring an additional 5,000 shares in the last quarter. Fosun International Ltd increased its position in shares of Edap Tms by 45.9% in the first quarter. Fosun International Ltd now owns 363,485 shares of the medical equipment provider’s stock worth $1,072,000 after acquiring an additional 114,342 shares in the last quarter. Finally, Naples Global Advisors LLC acquired a new stake in shares of Edap Tms in the fourth quarter worth $31,000. 10.07% of the stock is owned by institutional investors.
About Edap Tms
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).
Featured Story: How is the LIBOR rate calculated?
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.